AAM comments on Section 232 investigation on pharmaceuticalsAAM said tariffs will exacerbate drug shortages that hinder patient access today. Retailers come together to support legislation addressing organized retail crimeRetailers are urging passage of new bipartisan legislation that would establish a coordinated federal response to the growing problem of organized retail crime. Private Label Hall of Fame Class of 2025 inducted at PLMA conference The Class of 2025 consists of nine individuals who were honored in one of three categories. AAM commends Q1/Q2 House Bill reintroduction AAM said the bill will cut red tape, bring lower-cost medicines to patients faster and save money. Biosimilars Council weighs in on Matrix Global Advisors’ biosimilars report A Matrix Global Advisors report highlights current barriers and recommendations for robust competition and patient savings in the next decade. Kellyanne Conway to headline NACDS-PAC event at 2025 Annual Meeting Conway will keynote the Political Action Committee Breakfast during the 2025 NACDS Annual Meeting, set for April 26-29 in Palm Beach, Fla. Hugh Chancy, former NCPA president, presses for PBM reform in Congressional hearing Anticompetitive PBM tactics lead to higher costs, limited choices and pharmacy deserts, Chancy said. Jim Whitman to retire from NACDS Jim Whitman announced he will retire in June after nearly five decades at NACDS. NACDS issues Call to Action Feb. 26 virtual “PBM Patrol” Watch Party NACDS is urging members to watch The House Energy and Commerce Health Subcommittee's hearing on pharmacy benefit manager tactics on Feb. 26 at 10:00 am ET. AAM releases 2025 advocacy priorities, legislative reform recommendations The recommendations are a call to action to safeguard affordable generic and biosimilar medicines. 1 2 3 4 5 Next Last
